Compare Crescent Energy Company Class A Common Stock (CRGY) vs DexCom, Inc. (DXCM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Crescent Energy Company Class A Common Stock vs DexCom, Inc. — how do they compare? Crescent Energy Company Class A Common Stock trades at $12.9 (market cap $4.30B), while DexCom, Inc. trades at $83.36 (market cap $31.86B). The key difference: DexCom, Inc. is far larger — about 7.4× Crescent Energy Company Class A Common Stock's market cap, and Crescent Energy Company Class A Common Stock pays a 3.69% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Crescent Energy Company Class A Common Stock for 1 Days and DexCom, Inc. for 62 Days on average.
| CRGY | DXCM | |
|---|---|---|
Market Cap | $4.30B | $31.86B |
Volume | 15,201,625 | 3,607,070 |
Sector | Energy | Health |
52-Week High | $15.37 | $92.34 |
52-Week Low | $7.75 | $54.84 |
Typical Hold Time | 1 Days | 62 Days |
Enterprise Value | $9.31B | $31.32B |
Dividend Yield | 3.69% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
DexCom (DXCM) trades at $84.03, down 0.32% on the day, with strong fundamental performance including three consecutive quarterly EPS beats and robust 20.12% net income margin. The stock shows bearish technical signals with price near pivot point support at $84, while analyst consensus remains overwhelmingly positive with 81% buy ratings and $95.07 price target representing 13% upside potential. Recent news highlights expansion opportunities in Type 2 diabetes care and executive promotions.
DXCM presents a compelling growth story with expanding profit margins and consistent earnings outperformance, though technical weakness and premium valuation create near-term headwinds. The company's leadership in continuous glucose monitoring and Type 2 diabetes market expansion provide long-term catalysts, while competition and reimbursement risks require monitoring.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Crescent Energy Company Class A Common Stock
Crescent Energy acquires, develops, and produces oil and natural gas from onshore U.S. basins. Its portfolio includes producing assets with oil and natural gas exposure.
Read more on CRGY →About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →
